IndexIQ Advisors’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-11,439
Closed -$333K 1124
2020
Q4
$333K Buy
11,439
+1,181
+12% +$30.6K 0.01% 592
2020
Q3
$226K Buy
10,258
+555
+6% +$14.2K 0.01% 548
2020
Q2
$270K Buy
+9,703
New +$237K 0.01% 364
2018
Q1
Sell
-74,935
Closed -$2.15M 560
2017
Q4
$2.15M Buy
74,935
+28,832
+63% +$907K 0.08% 133
2017
Q3
$1.26M Buy
46,103
+20,913
+83% +$463K 0.05% 163
2017
Q2
$528K Buy
+25,190
New +$532K 0.03% 249

Other funds holding ACLS

IndexIQ Advisors's ACLS Position: Q1 2021 in Review

IndexIQ Advisors sold out of Axcelis (ACLS) in Q1 2021, closing a stake of 11,439 shares — an estimated $333K sold.

IndexIQ Advisors first reported a position in ACLS in Q2 2017 and held it in 6 quarters. The position peaked at $2.15M in Q4 2017. 193 funds tracked by Wall St. Rank hold ACLS as of Q1 2021.

  • IndexIQ Advisors reported no remaining Axcelis position as of Q1 2021 after selling out during the quarter.
  • IndexIQ Advisors sold 11,439 Axcelis shares in Q1 2021, an estimated $333K.
  • IndexIQ Advisors first reported a position in Axcelis in Q2 2017 and held it in 6 quarters.
  • IndexIQ Advisors's Axcelis position peaked at $2.15M in Q4 2017.
  • 193 funds tracked by Wall St. Rank held Axcelis as of Q1 2021.

Based on IndexIQ Advisors's 13F filing for Q1 2021, filed 7 May 2021.